Marex Group plc (“Marex”), a diversified global financial services platform, today announced that it has launched an initial public offering (“IPO”) of its common shares. A total of 15,384,615 common shares are being offered, of which 25% will be offered by Marex and 75% will be offered by certain selling stockholders (the “Offering Stockholders”).
In connection with the offering, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,307,692 shares of common stock to cover over-allotments. The IPO price is currently estimated at $18 to $21 per share. Marex's common stock will be traded on the Nasdaq Global Select Market under the ticker symbol “MRX.”
Barclays, Goldman Sachs & Company (NYSE:). LLC, Jeffries & Keefe, Bruyette & Woods; Stifel Companyacting as joint lead bookrunning managers and representatives of the underwriters for the proposed offering.
Citigroup, UBS Investment Bank, Piper Sandler and HSBC are acting as bookrunners for the proposed offering. Drexel Hamilton and Loop Capital Markets are acting as joint managers of the proposed product.
The proposed offering will be made only by means of a prospectus. A copy of the preliminary prospectus relating to the proposed offering is available below.
- Within Barclays Capital Inc. broadridge financial solutions (NYSE:), 1155 Long Island Avenue, Edgewood, NY 11717, phone: 1-888-603-5847, or email: barclaysprospectus@broadridge.com;
- Goldman Sachs & Co. LLC, Attn: Prospectus Division, 200 West Street, New York, New York 10282, Phone: 1-866-471-2526, or Email: Prospectus-ny@ny.email.gs.com;
- Jefferies LLC, Attention: Stock Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at (877) 821-7388, or by email. Prospectus_Department@Jefferies.com; or
- Keefe, Bruyette & Woods Inc., 787 Seventh Avenue, Fourth Floor, New York, NY 10019, Attention: Equity Capital Markets, or by calling toll-free (800) 966-1559 or by email. USCapitalMarkets@kbw.com.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the effective date of the registration statement. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor does it constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification. It does not constitute a solicitation or sale. Under the securities laws of that jurisdiction.